Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status

Open Access

Peer-reviewed

Research Article

Maria Planck,

Affiliation Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Medicon Village, Lund, Sweden
⨯
Karolina Edlund,

Affiliation Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⨯
Johan Botling,

Affiliation Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⨯
Patrick Micke,

Affiliation Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⨯
Sofi Isaksson,

Affiliation Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Medicon Village, Lund, Sweden
⨯
Johan Staaf

* E-mail: johan.staaf@med.lu.se

Affiliations Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Medicon Village, Lund, Sweden, CREATE Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, Lund, Sweden
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Cancer genomics
Is the Subject Area "Cancer genomics" applicable to this article?

Thanks for your feedback.
Genome analysis
Is the Subject Area "Genome analysis" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.